STEMCELL Technologies

What STEMCELL Technologies does

STEMCELL Technologies, founded in 1993 by UBC professor Dr. Allen Eaves and headquartered in Vancouver, British Columbia, is Canada's largest privately held biotech company. It develops and manufactures specialized reagents, instruments, software, and contract research services for life science research, with core platform technologies spanning cell isolation (EasySep immunomagnetic, RosetteSep immunodensity, SepMate tubes, RoboSep automation), pluripotent and hematopoietic stem cell culture media (mTeSR Plus, StemSpan, STEMdiff, MesenCult), organoid culture systems (IntestiCult, plus lung/liver organoid kits), and genome editing (ArciTect CRISPR-Cas9). The portfolio also includes colony-counting instruments (STEMvision), limiting dilution software (L-Calc), hPSC genetic and qPCR analysis tools, and a pipeline of primary cells, antibodies, ELISA kits, and transfection systems (CellPore mechanoporation). The company's intellectual property is anchored by CRISPR-Cas9 licensing under US patent 8,697,359 and related family members.

The company operates a hybrid go-to-market combining direct e-commerce via stemcell.com, regional offices in North America, Europe, Asia, and Oceania, an international distributor network, and eProcurement integration for institutional buyers, generating 97% export sales across 100 countries to over 25,000 customers. Revenue is diversified across catalog reagent sales (per-unit pricing), instruments (hardware sales with service contracts), contract research services (biopharma testing, organoid assays, toxicity testing, hPSC characterization), training programs, and custom solutions — with primary customer segments in life science research and cell/gene therapy development, plus secondary pharmaceutical/drug-discovery customers. The firm is ISO 13485, ISO 9001, and ISO 14001 certified, employs nearly 1,800 people, and has reported 18% annual growth sustained over three decades. Recent strategic activity includes the June 2025 acquisition of Cellular Highways Ltd (microfluidics cell sorting), the January 2024 acquisition of Propagenix, the 2025 launch of the STEMprep Tissue Dissociator System, and $49.9 million in cumulative federal support under Canada's Biomanufacturing and Life Sciences Strategy.

Name

STEMCELL Technologies

Legal name

STEMCELL Technologies Canada Inc.

Website

https://stemcell.com

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

501–1,000 employees

Short description

STEMCELL Technologies, founded in 1993 and headquartered in Vancouver, manufactures specialized reagents, instruments, software, and contract research services for cell biology, stem cell, organoid, and genome-editing research, selling to over 25,000 life science researchers and cell therapy developers across 100 countries.

Ownership category

akta.pro rank

Product category

Life Science Research Reagents and Tools

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Analytical Laboratory Instrument Manufacturing (334516)

SIC

Biological Products, (No Disgnostic Substances) (2836), Services-Commercial Physical & Biological Research (8731), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Cell Processing & Ancillary Materials (media, cytokines, beads, vectors, disposables) (HLAAABAH)

akta.pro secondary industries

Stem Cell Therapies (MSC/iPSC/HSC-derived) (HLAAABAE), Cell Therapy Enabling Technologies (gene editing, cell engineering, delivery methods) (HLAAABAL), Cell Therapy Quality, Analytics & Release Testing (potency, sterility, comparability) (HLAAABAK)

Keywords

• Cell isolation reagents
• Stem cell culture media
• CRISPR genome editing
• Organoid culture systems
• Cell separation instruments

Headquarters

HQ city

Vancouver

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Research Reagents and Tools: Sale of specialized reagents including cell culture media, antibodies, cytokines, proteins, cell isolation products, small molecules, and laboratory equipment for life science research.
2. Instruments and Software: Sale and service of laboratory instruments including cell separation instruments (RoboSep), colony counting systems (STEMvision), and software tools (L-Calc, STEMSOFT).
3. Contract Research Services: Fee-for-service offerings including biopharmaceutical testing, immunological assessment, hematopoietic cell services, mesenchymal cell services, pluripotent stem cell characterization, toxicity testing, and organoid services.
4. Training Programs: On-demand training, live virtual training, and hands-on training programs for various cell culture and analysis techniques, as well as proficiency testing services.
5. Custom Solutions: Custom cell culture media, custom cell separation kits, and custom primary cell products tailored to specific customer research needs.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels9 records

Core offering

STEMCELL Technologies manufactures and sells specialized reagents, instruments, software, and services for life science research, with a focus on cell isolation (EasySep, RosetteSep, SepMate), cell culture media for pluripotent and hematopoietic stem cells (mTeSR, MethoCult, StemSpan), CRISPR-Cas9 genome editing (ArciTect), organoid culture media, automated instruments (RoboSep, STEMvision, Highway1), analysis software (L-Calc, CRISPR Guide Design Tool), contract research services, and training programs.

Product overview

STEMCELL Technologies provides a comprehensive portfolio of reagents, tools, instruments, software, and services for life science research, specializing in cell biology and stem cell research. The company's product ecosystem centers on key platform technologies: EasySep™ for immunomagnetic cell isolation, ArciTect™ for CRISPR-Cas9 genome editing, and specialized cell culture media brands (mTeSR™ Plus, StemSpan™, STEMdiff™, MesenCult™) for pluripotent stem cell and hematopoietic cell maintenance and differentiation. Supporting these core platforms are RoboSep™ automated instruments, organoid media kits (IntestiCult™ Plus), antibody reagents, ELISA assay kits, and software tools including L-Calc™ for limiting dilution analysis, CRISPR Guide Design Tools, and hPSC Genetic Analysis Tool. The company also offers contract research services, custom solutions, and training programs. Recent additions include the Highway1 microfluidics-based cell sorting platform and STEMprep Tissue Dissociator System acquired/launched in 2025.

Differentiator

Problem solved

Functional benefit

Brands

• EasySep: Immunomagnetic cell isolation technology for isolating highly purified cell subsets
• RosetteSep
• SepMate
• RoboSep
• mTeSR
• MesenCult
• STEMdiff
• StemSpan
• ArciTect
• MethoCult
• MyeloCult
• ImmunoCult
• IntestiCult
• PneumaCult
• NeuroCult
• CellPore
• L-Calc
• STEMvision

Products and services

• EasySep Immunomagnetic Cell Isolation Immunomagnetic cell isolation technology that isolates highly purified immune cell subsets in as little as 8 minutes using a simple pour procedure; works with whole blood, PBMCs, bone marrow, splenocytes, and leukopaks for life science researchers.
• ArciTect CRISPR-Cas9 Genome Editing System RNP-based CRISPR-Cas9 system for high-efficiency genome editing in difficult-to-manipulate cell types including human pluripotent stem cells, hematopoietic stem and progenitor cells, and T cells; includes an integrated Guide RNA Design Tool.
• mTeSR Plus Maintenance Medium Defined, stabilized maintenance medium for human pluripotent stem cells (hPSCs) that supports a weekend-free feeding schedule through enhanced buffering capacity.
• StemSpan Hematopoietic Cell Culture Media and Supplements Serum-free culture media and supplements for the expansion and differentiation of hematopoietic stem and progenitor cells (HSPCs) under defined, xeno-free conditions.
• STEMdiff PSC Differentiation Media Kits Standardized media kits and protocols for differentiating pluripotent stem cells into specialized cell types and organoids across multiple lineages.
• MesenCult Expansion Kit Media kit for deriving and enriching mesenchymal stromal cells (MSCs) from mouse tissue as early as passage 0, skipping serial passaging.
• RoboSep Automated Cell Isolation Instrument Automated cell isolation instrument that runs the EasySep workflow hands-free, increasing throughput and minimizing operator handling of samples containing infectious agents.
• STEMvision Automated Colony Counter Automated instrument that standardizes and accelerates hematopoietic colony-forming unit (CFU) assay counting for greater reproducibility.
• L-Calc Software Software for limiting dilution analysis of hematopoietic stem cell assays, determining the frequency of cells capable of a defined response in LTC-IC, CAFC, CRU, and SRC formats.
• hPSC Genetic Analysis Tool Web-based application used with the hPSC Genetic Analysis Kit to rapidly detect genetic abnormalities in human pluripotent stem cell cultures.
• qPCR Analysis Tool Web-based tool that accepts qPCR data, performs statistical analyses, assists interpretation, and provides visual representation for researchers.
• CRISPR Guide Design Tools Web-based computational tools that use best practices and algorithms to design optimal crRNA and sgRNA sequences for every gene in human and mouse genomes, considering on-target/off-target scores, relative position, SNP probability, and isoform coverage.
• RosetteSep Immunodensity Cell Isolation Immunodensity cell isolation technology that obtains untouched cell subsets directly from whole blood by incorporating immune cell isolation into a standard centrifugation step.
• SepMate PBMC Isolation Tubes PBMC isolation tubes that standardize processing and isolate peripheral blood mononuclear cells in 15 minutes; can be combined with RosetteSep for specific immune cell subset isolation.
• CloneR Single-Cell Cloning Supplement Defined supplement for single-cell cloning of human embryonic stem cells and induced pluripotent stem cells, improving cloning efficiency.
• ELISA Kits Complete, ready-to-use ELISA kits with pre-coated 96-well strip microplates for highly sensitive and accurate quantification of analytes in biological samples, available for human and mouse targets.
• Organoid Media Kits Optimized media kits for growing and maintaining organoids derived from primary tissue and human pluripotent stem cells across intestinal, hepatic, pulmonary, neural, and other organ systems.
• Gentle Cell Dissociation Reagent (GCDR) Reagent for dissociating cells and organoids from Matrigel and other matrices for downstream cell culture workflows.
• Primary and Cultured Cells High-quality human primary cells and iPSC-derived cells including hematopoietic stem cells, mesenchymal progenitors, T cells, and tissue-specific cells, supplied with donor and HLA data.
• Antibodies Primary and secondary antibodies validated to work with STEMCELL cell isolation and cell culture reagents, including ICC-validated antibodies for phenotyping, purity assessments, and immunocytochemistry.
• IntestiCult Plus Organoid Growth Medium Organoid growth medium for the culture and maintenance of intestinal organoids from primary tissue or hPSC-derived sources.
• ImmunoCult Human T Cell Activators GMP-grade reagents for human T cell activation and expansion, used in cell therapy development and manufacturing workflows.
• CellPore Transfection System Mechanoporation-based transfection system for intracellular delivery of molecules into cells, used in gene editing and cell engineering protocols.
• Highway1 Cell Sorting Instrument Microfluidics-based cell sorting platform with VACS technology acquired in June 2025 from Cellular Highways Ltd; designed to support advanced cell processing for cell and gene therapy research and manufacturing.
• STEMprep Tissue Dissociator System Integrated mechanical and enzymatic platform launched in June 2025 to streamline tissue dissociation and processing for stem cell research workflows.
• Contract Research Services Fee-for-service offerings including biopharmaceutical and biosimilar testing, immunological assessment, hematopoietic and mesenchymal cell services, pluripotent stem cell characterization, toxicity testing, and organoid assays for biopharmaceutical and academic clients.
• Training Programs On-demand, live virtual, and hands-on training programs for cell isolation, organoid culture, genome editing, and related techniques, plus proficiency testing services for life science teams.
• Custom Cell Culture Media and Reagent Solutions Custom-manufactured cell culture media, cell separation kits, and primary cell products tailored to specific customer research and bioprocess requirements.

Quantifiable outcome

• Highly purified immune cell subsets isolated in as little as 8 minutes
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Four partnerships are on record, tiered core, foundational and minor.

• TTP Group Ltd (Cellular Highways acquisition)coreTechnology or Integration · 2 June 2025STEMCELL acquired Cellular Highways Ltd from TTP Group Ltd, gaining access to the Highway1 cell sorting instrument and VACS™ technology. This acquisition enhances STEMCELL's development of advanced cell processing instruments and supports cell and gene therapy research.
• UBC (University of British Columbia)foundationalStrategic or Co-development Partner · 1 January 1993STEMCELL Technologies was founded in 1993 by UBC professor Dr. Allen Eaves, originating from university lab research. The company maintains deep ties with UBC and the broader BC life sciences ecosystem that enabled its rise to become Canada's largest biotech company.
• Terry Fox LaboratoryfoundationalStrategic or Co-development Partner · 1 January 1981Dr. Allen Eaves co-founded the Terry Fox Laboratory in 1981, which laid the groundwork for B.C.'s life sciences ecosystem. This foundational partnership enabled the research environment from which STEMCELL emerged.
• Malachite ManagementminorImplementation/ SI/ Consulting PartnerAssociation management services provided by Malachite Management for professional associations in the life sciences field.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

Emerging players

• REPROCELL: Japan-based stem cell research reagents, iPSC services, and regenerative medicine tools company. Competes with STEMCELL in pluripotent stem cell media and stem cell-related products, with particular strength in Asia-Pacific markets.
• CellGenix: German supplier of GMP-grade raw materials and reagents for cell and gene therapy manufacturing (cytokines, media, T cell activation reagents). Direct overlap with STEMCELL's ImmunoCult and clinical-grade reagent offerings for cell therapy developers.

Broad incumbents

• Lonza Group: Swiss CDMO and cell & gene therapy manufacturing solutions provider. Adjacent competitor as Lonza expands into GMP-grade cell therapy reagents and media, increasingly overlapping with STEMCELL's clinical/commercial cell therapy offering.
• Thermo Fisher Scientific: Largest global life science tools and reagents conglomerate (Gibco media, Invitrogen antibodies, etc.). Competes with STEMCELL across nearly every product category but with much broader catalog, larger enterprise salesforce, and frequent portfolio bundling.
• BD Biosciences: Division of Becton Dickinson offering cell isolation, flow cytometry, and cell therapy manufacturing solutions. Competes with STEMCELL in cell separation and cell therapy workflow tools but as part of a broader medical device and life sciences portfolio.
• Cytiva (Danaher): Bioprocessing and cell therapy manufacturing tools business within Danaher. Competes with STEMCELL in upstream cell processing instruments, media, and single-use technologies for cell and gene therapy manufacturing.
• Corning Life Sciences: Major supplier of cell culture media, sera, and plasticware to research and bioproduction customers. Competes with STEMCELL across cell culture consumables, particularly at high-volume academic accounts and bioproduction customers.
• Sartorius: German bioprocessing supplier with growing exposure to cell and gene therapy manufacturing. Competes with STEMCELL in cell therapy production equipment and consumables, particularly following its BIA Separations and other acquisitions.

Direct peers

• Miltenyi Biotec: Privately held German life science tools company specializing in magnetic cell separation (MACS technology), flow cytometry, and cell/gene therapy manufacturing reagents. Closest direct competitor to STEMCELL's EasySep cell isolation and cell therapy reagent franchises.
• Bio-Techne: U.S. public life science reagents and tools company (R&D Systems, Tocris, ProteinSimple, ExoDx). Direct competitor in stem cell media, cytokines, antibodies, and analytical tools; comparable in scientific customer base and product breadth.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/stemcelltech
• Facebookfacebook.com/stemcelltechnologies
• LinkedInlinkedin.com/company/stemcell-technologies

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries1 record

Funding overview

Funding rounds3 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about STEMCELL Technologies